Definitive Contract HDTRA121C0008
Award Date 1/14/21
Potential Completion Date 8/28/23
Potential Value $1M
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This is a $1,271,417.59 Cost Plus Fixed Fee contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Genecapture, Inc., a for-profit startup company. The contract is for a Small Business Technology Transfer (STTR) Phase II effort focused on developing infectious disease diagnostics and differentiation of viral versus bacterial infections for point-of-care applications. The contract was set aside for small businesses. Genecapture specializes in rapid infectious disease...
- The Defense Threat Reduction Agency (DTRA) awarded Genecapture, Inc. a $4.54 million Phase III Small Business Technology Transfer (STTR) contract on November 3, 2023, to develop infectious disease diagnostics capable of differentiating viral versus bacterial infections for point-of-care applications. This definitive contract, structured as Cost Plus Fixed Fee pricing, will be performed in Huntsville, Alabama, with an ultimate completion date of July 31, 2026. The contract carries no small...
- This is a Small Business Technology Transfer (STTR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA) to Genecapture, Inc., a for-profit startup company. The $150,523.52 firm-fixed-price contract is for the development of infectious disease diagnostics and differentiation of viral vs. bacterial infections for point-of-care applications. Genecapture specializes in rapid pathogen detection solutions using their patented CAPTURE technology. This contract supports DTRA's efforts...
- The Defense Health Agency (DHA) awarded a $249,938.77 Small Business Innovation Research (SBIR) Phase I contract to Genecapture, Inc., a for-profit startup company located at the Hudson Alpha Institute for Biotechnology. The contract is for the project titled "Expanding Genecapture's Rapid Portable Invasive Fungal Infection (IFI) Diagnostics for Wound Infections." Genecapture develops rapid infectious disease detection solutions using their patented CAPTURE technology, which identifies...
- This federal contract award was made by the Department of the Army Medical Command to Genecapture, Inc., a for-profit startup company, under the Small Business Innovation Research (SBIR) program. The contract, valued at $249,959.25, is for Phase I feasibility research on Genecapture's CAPTURE technology, which enables rapid identification of genetic signatures of pathogens for infectious disease detection and diagnosis. The award has a total small business set-aside designation. Genecapture...
- Genecapture, Inc. was awarded a definitive contract valued at $1,099,956.91 by the Department of the Army Medical Command to conduct research and development under the Small Business Innovation Research (SBIR) Program Phase II. The contract supports Proposal No. H2-0647 titled "Genecapture's Fieldable Diagnostic Platform for Rapid ID and AST of Wound Pathogens." Research will be conducted in Huntsville, Alabama over a period of performance from September 2021 through January 2024 under...
- The Department of the Air Force Materiel Command Research Laboratory awarded a $284,827 Other Transaction Agreement to Genecapture, Inc., a for-profit small business startup, to research and develop a ruggedized and upgraded version of a commercially available pathogen detector that can be deployed in forward environments. This award is not set aside for any specific business type. Genecapture has received prior Small Business Innovation Research (SBIR) Phase II contracts from the Army,...
- This is a $1,140,081.00 Small Business Innovation Research (STTR) Phase II contract awarded by the Defense Threat Reduction Agency to Biological Mimetics, Inc., a biotechnology company that combines biology and engineering to identify and prevent global infections. The contract is for research and development services related to infectious diseases, vaccines, diagnostics, and therapeutics. Biological Mimetics has previously received grants and contracts from federal agencies like the National...
- This federal contract award to Geneinfosec Inc. Biotech Division, a self-certified small disadvantaged business, is for the development of a molecular cryptography solution to enhance data and network security through DNA-based approaches. The $1,248,980.00 Firm Fixed Price contract was awarded by the Air Force Research Laboratory (AFRL), a defense agency, under the Small Business Innovation Research (SBIR) program. The award supports Phase II development work building on previous Phase I and II...
- This federal contract award, valued at $85,340.00, was issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to Genedata (USA), Inc., a foreign-owned, self-certified small disadvantaged business. The contract provides for the software license, maintenance, and support of Genedata Screener, the company's proprietary bioinformatics software platform, to support critical research initiatives,...